Mentor Announces Completion Of Subject Enrollment Into Phase IIIb Pivotal Trial For B

		Plastic Surgery user forums > Plastic Surgery News
Mentor Announces Completion Of Subject Enrollment Into Phase IIIb Pivotal Trial For B

Plastic Surgery News Latest Plastic Surgery News

LinkBack

Thread Tools

Display Modes

#1 (permalink)

01-31-2008, 03:25 PM

News Feeder4 News Feeder4 is offline

Senior Member

Join Date: Jun 2007

Posts: 6,897

My Photos: (0)

Mentor Announces Completion Of Subject Enrollment Into Phase IIIb Pivotal Trial For B

Mentor Corporation (NYSE:MNT), a leading supplier of medical products for the global aesthetic market, announced that subject enrollment and initial dosing in its pivotal Phase IIIb study of its investigational botulinum toxin type A for the reduction of glabellar rhytides (frown lines) by intramuscular injection has been completed.
More...

« Sporting Events May Hurt Fans' Hearts | Spectators' Emotional Stress Linked To Heart Attacks »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts vB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On

All times are GMT. The time now is 11:03 PM.